Morning Movers 01/06: (BDSI) (SABA) (XIDE) (AGEN) Higher; (DRRX) (RFMD) (IART) (PSMT) (SNTA) Lower
Tweet
Share
E-mail
Get Alerts BDSI Hot Sheet
Join SI Premium – FREE
BioDelivery Sciences International, Inc. (Nasdaq: BDSI) 124% HIGHER; announced the signing of a worldwide license and development agreement with Endo Pharmaceuticals (Nasdaq: ENDP) for the exclusive rights to develop and commercialize BEMA Buprenorphine for the treatment of chronic pain. Click here to see the full report.
DURECT Corporation (Nasdaq: DRRX) 36.4% LOWER; announced top-line results from the U.S. pivotal Phase III clinical study for POSIDUR® known as BESST which did not meet statistical significance. Click here to see the full report.
RF Micro Devices, Inc. (Nasdaq: RFMD) 20% LOWER; has provided a quarterly financial update for its third fiscal quarter, ended December 31, 2011. RFMD's revenue for the December 2011 quarter was approximately $225 million, versus the consensus of $250.2 million. Click here to see the full report.
Integra (Nasdaq: IART) 16.4% LOWER; issues preliminary Q4 results: adj-EPS in the range of 65-70 cents, which compares to the Street estimate of 79 cents. Sees sales $202-$203 million, which compares to the Street estimate of $212.8 million. Sees FY12 sales up 8 percent. Sees adj-EPS up 8-9 percent. Says got an FDA warning letter on its Plainsborough, NJ facility.
Pricesmart, Inc. (NASDAQ: PSMT) 16.2% LOWER; reported Q1 EPS of $0.51, $0.07 worse than the analyst estimate of $0.58. Revenue for the quarter came in at $468.3 million versus the consensus estimate of $472.51 million.
Synta Pharmaceuticals Corp. (NASDAQ: SNTA) 14.4% LOWER; has priced an underwritten public offering of 7,000,000 shares of its common stock at a price to the public of $4.40 per share.
EnerNOC Inc. (Nasdaq: ENOC) 13% LOWER; falling following a compliance filing at Federal Energy Regulator Commission from PJM. Click here to see the full report.
Saba Software, Inc. (NASDAQ: SABA) 12.4% HIGHER; reported Q2 EPS of ($0.10), $0.01 better than the analyst estimate of ($0.11). Revenue for the quarter came in at $30.6 million versus the consensus estimate of $31.72 million. Saba Software, Inc. reaffirmed FY2012 guidance.
Spreadtrum Communications (Nasdaq: SPRD) 11.6% LOWER; probably falling in sympathy with RF Micro. Notably, the stock broke below the 200-day yesterday and the $19 level this morning.
Exide Technologies (NASDAQ: XIDE) 11.4% HIGHER; Wedbush upgraded the stock from Neutral to Outperform with a price target of $5.00. Click here to see the full report.
Vical Incorporated (Nasdaq: VICL) 11.2% LOWER; has priced an underwritten public offering of 13,333,334 shares of its common stock at a price to the public of $3.75 per share.
Agenus (Nasdaq: AGEN) 10.2% HIGHER; stock continuing higher today after touching and bouncing off of the 200-day SMA late yesterday. Volume is very heavy today.
Zogenix, Inc. (NASDAQ: ZGNX) 10.1% HIGHER; William Blair initiates coverage on shares of Zogenix with an Outperform rating and $6 price target.
Jazz Pharmaceuticals (Nasdaq: JAZZ) 9.4% HIGHER; provides financial guidance for 2012 as follows: Revs of $465 - $490 million, versus $462.8 million expected on the Street; Product sales of $460 - $485 million; and Adjusted EPS of $4.00 - $4.15. The Street sees $3.40
DURECT Corporation (Nasdaq: DRRX) 36.4% LOWER; announced top-line results from the U.S. pivotal Phase III clinical study for POSIDUR® known as BESST which did not meet statistical significance. Click here to see the full report.
RF Micro Devices, Inc. (Nasdaq: RFMD) 20% LOWER; has provided a quarterly financial update for its third fiscal quarter, ended December 31, 2011. RFMD's revenue for the December 2011 quarter was approximately $225 million, versus the consensus of $250.2 million. Click here to see the full report.
Integra (Nasdaq: IART) 16.4% LOWER; issues preliminary Q4 results: adj-EPS in the range of 65-70 cents, which compares to the Street estimate of 79 cents. Sees sales $202-$203 million, which compares to the Street estimate of $212.8 million. Sees FY12 sales up 8 percent. Sees adj-EPS up 8-9 percent. Says got an FDA warning letter on its Plainsborough, NJ facility.
Pricesmart, Inc. (NASDAQ: PSMT) 16.2% LOWER; reported Q1 EPS of $0.51, $0.07 worse than the analyst estimate of $0.58. Revenue for the quarter came in at $468.3 million versus the consensus estimate of $472.51 million.
Synta Pharmaceuticals Corp. (NASDAQ: SNTA) 14.4% LOWER; has priced an underwritten public offering of 7,000,000 shares of its common stock at a price to the public of $4.40 per share.
EnerNOC Inc. (Nasdaq: ENOC) 13% LOWER; falling following a compliance filing at Federal Energy Regulator Commission from PJM. Click here to see the full report.
Saba Software, Inc. (NASDAQ: SABA) 12.4% HIGHER; reported Q2 EPS of ($0.10), $0.01 better than the analyst estimate of ($0.11). Revenue for the quarter came in at $30.6 million versus the consensus estimate of $31.72 million. Saba Software, Inc. reaffirmed FY2012 guidance.
Spreadtrum Communications (Nasdaq: SPRD) 11.6% LOWER; probably falling in sympathy with RF Micro. Notably, the stock broke below the 200-day yesterday and the $19 level this morning.
Exide Technologies (NASDAQ: XIDE) 11.4% HIGHER; Wedbush upgraded the stock from Neutral to Outperform with a price target of $5.00. Click here to see the full report.
Vical Incorporated (Nasdaq: VICL) 11.2% LOWER; has priced an underwritten public offering of 13,333,334 shares of its common stock at a price to the public of $3.75 per share.
Agenus (Nasdaq: AGEN) 10.2% HIGHER; stock continuing higher today after touching and bouncing off of the 200-day SMA late yesterday. Volume is very heavy today.
Zogenix, Inc. (NASDAQ: ZGNX) 10.1% HIGHER; William Blair initiates coverage on shares of Zogenix with an Outperform rating and $6 price target.
Jazz Pharmaceuticals (Nasdaq: JAZZ) 9.4% HIGHER; provides financial guidance for 2012 as follows: Revs of $465 - $490 million, versus $462.8 million expected on the Street; Product sales of $460 - $485 million; and Adjusted EPS of $4.00 - $4.15. The Street sees $3.40
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- William Blair Starts Surrozen Inc. (SRZN) at Outperform
- William Blair Upgrades Moderna (MRNA) to Outperform, 'we believe Moderna has a clear line of sight to revenue diversification from the COVID business
- Saratoga Investment prices $85M in notes due 2031 at 8.00%
Create E-mail Alert Related Categories
Special ReportsRelated Entities
William Blair, Morning MoversSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
